Key result
Percutaneous left atrial appendage closure in diabetic patients showed similar rates of periprocedural major adverse cardiac and cerebrovascular events compared to controls.
Why the study?
Is percutaneous left atrial appendage closure safe and effective in patients with diabetes mellitus compared to those without?
Observational (n=78)
Open-label
No
Is percutaneous left atrial appendage closure safe and effective in patients with diabetes mellitus compared to those without?
Despite higher baseline surgical risk scores, patients with diabetes mellitus undergoing percutaneous left atrial appendage closure have similar safety and efficacy outcomes at 6 months compared to those without diabetes.
Answers are grounded in this paper and cite their sources.
Supports periprocedural safety of LAA closure in diabetes; leaves open randomized confirmation of efficacy.
BACKGROUND: Left atrial appendage closure is a preventive treatment of atrial fibrillation-related thrombo-embolism. Patients with diabetes mellitus have increased risk for a negative outcome in percutaneous cardiac interventions. We assessed whether percutaneous left atrial appendage closure is safe and effective in patients with diabetes mellitus. METHODS: We included 78 patients (mean age of 74.4 ± 8.3 years) with indication for left atrial appendage closure in an open-label observational single-centre study. Pre- and periprocedural risk was elevated in patients with diabetes mellitus (Euro II-Score: 6.6 ± 3.7 vs 3.9 ± 1.9, p < 0.01; Society of Thoracic Surgeons (STS)-Score: 4.0 ± 2.5 vs 2.6 ± 1.2, p < 0.01). Procedural success was similar. Periprocedural major adverse cardiac and cerebrovascular events occurred in one patient from the control group (2.1%), whereas patients with diabetes mellitus had no events ( p = 0.672). Follow-up of 6 months revealed no bleeding complication in both groups. No stroke occurred in follow-up, and left atrial appendage flow velocity reduction (55.6 ± 38.6 vs 51.4 ± 19.1 cm/s, p = 0.474) and rate of postinterventional leakage in the left atrial appendage were comparable (0% vs 2.1%, p = 0.672). CONCLUSION: Despite patients with diabetes mellitus are high-risk patients, the outcome of percutaneous left atrial appendage closure is similar to patients without diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Azizy et al. (2017) conducted an observational in Indication for left atrial appendage closure (n=78). Percutaneous left atrial appendage closure vs. Patients without diabetes mellitus was evaluated on Periprocedural major adverse cardiac and cerebrovascular events (p=0.672). Percutaneous left atrial appendage closure in diabetic patients showed similar rates of periprocedural major adverse cardiac and cerebrovascular events compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: